ReShape Lifesciences (RSLS) Revenue & Revenue Breakdown
ReShape Lifesciences Revenue Highlights
Latest Revenue (Y)
$8.68M
Latest Revenue (Q)
$1.97M
Main Segment (Y)
Product
Main Geography (Y)
United States
ReShape Lifesciences Revenue by Period
ReShape Lifesciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $8.68M | -22.79% |
| 2022-12-31 | $11.24M | -17.35% |
| 2021-12-31 | $13.60M | 20.36% |
| 2020-12-31 | $11.30M | -25.12% |
| 2019-12-31 | $15.09M | 2387.02% |
| 2018-12-31 | $606.71K | -52.86% |
| 2017-12-31 | $1.29M | 63.62% |
| 2016-12-31 | $786.66K | 169.40% |
| 2015-12-31 | $292.00K | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | -100.00% |
| 2012-12-31 | $312.00K | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2007-12-31 | - | 100.00% |
| 2006-12-31 | - | 100.00% |
| 2005-12-31 | - | 100.00% |
| 2004-12-31 | - | 100.00% |
| 2003-12-31 | - | - |
ReShape Lifesciences generated $8.68M in revenue during NA 2023, up -22.79% compared to the previous quarter, and up 1430.34% compared to the same period a year ago.
ReShape Lifesciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $1.97M | 1.08% |
| 2024-03-31 | $1.94M | -1.92% |
| 2023-12-31 | $1.98M | -8.03% |
| 2023-09-30 | $2.15M | -4.39% |
| 2023-06-30 | $2.25M | -1.44% |
| 2023-03-31 | $2.29M | -26.46% |
| 2022-12-31 | $3.11M | 11.15% |
| 2022-09-30 | $2.80M | -3.25% |
| 2022-06-30 | $2.89M | 18.52% |
| 2022-03-31 | $2.44M | -22.34% |
| 2021-12-31 | $3.14M | -15.26% |
| 2021-09-30 | $3.71M | 5.07% |
| 2021-06-30 | $3.53M | 9.56% |
| 2021-03-31 | $3.22M | 0.47% |
| 2020-12-31 | $3.21M | -10.99% |
| 2020-09-30 | $3.60M | 111.63% |
| 2020-06-30 | $1.70M | -38.97% |
| 2020-03-31 | $2.79M | -31.14% |
| 2019-12-31 | $4.05M | 15.22% |
| 2019-09-30 | $3.52M | -21.01% |
| 2019-06-30 | $4.45M | 44.76% |
| 2019-03-31 | $3.07M | -328.23% |
| 2018-12-31 | $-1.35M | -484.57% |
| 2018-09-30 | $350.24K | -46.40% |
| 2018-06-30 | $653.37K | -31.22% |
| 2018-03-31 | $950.00K | 19.64% |
| 2017-12-31 | $794.03K | 120.55% |
| 2017-09-30 | $360.02K | 286.87% |
| 2017-06-30 | $93.06K | 132.42% |
| 2017-03-31 | $40.04K | -71.78% |
| 2016-12-31 | $141.90K | -52.18% |
| 2016-09-30 | $296.76K | 7.52% |
| 2016-06-30 | $276.00K | 283.33% |
| 2016-03-31 | $72.00K | -51.68% |
| 2015-12-31 | $149.00K | 132.81% |
| 2015-09-30 | $64.00K | -18.99% |
| 2015-06-30 | $79.00K | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | -100.00% |
| 2012-06-30 | $188.40K | 53.06% |
| 2012-03-31 | $123.09K | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | 100.00% |
| 2008-03-31 | - | 100.00% |
| 2007-12-31 | - | - |
ReShape Lifesciences generated $1.97M in revenue during Q2 2024, up 1.08% compared to the previous quarter, and up 85.92% compared to the same period a year ago.
ReShape Lifesciences Revenue Breakdown
ReShape Lifesciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 18 |
|---|---|
| Product | $606.71K |
ReShape Lifesciences's latest annual revenue breakdown by segment (product or service), as of Dec 18: Product (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|
| Product | $335.95K | $633.55K | $941.43K |
| Product And Service Other | $14.29K | $19.82K | $8.57K |
ReShape Lifesciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 18: Product (95.92%), and Product And Service Other (4.08%).
ReShape Lifesciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Australia | $526.00K | $688.00K | $1.04M |
| United States | $7.13M | $9.23M | $10.30M |
| Europe | $956.00K | $1.25M | $2.13M |
| Rest of world | $62.00K | $70.00K | $137.00K |
ReShape Lifesciences's latest annual revenue breakdown by geography, as of Dec 23: United States (82.21%), Europe (11.02%), Australia (6.06%), and Rest of world (0.71%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AUSTRALIA | $103.00K | - | - | - | - | - | - | - | - | - | - | - | - |
| UNITED STATES | $1.66M | - | - | - | - | - | - | - | - | - | - | - | - |
| Non-US | $1.00K | - | - | - | - | - | - | - | - | - | - | - | - |
| Europe | $198.00K | $198.00K | $201.00K | $258.00K | $193.00K | $304.00K | $243.00K | $206.00K | $389.00K | $414.00K | $505.00K | $653.00K | $590.00K |
| Australia | - | $102.00K | $107.00K | $139.00K | $123.00K | $157.00K | $155.00K | $164.00K | $188.00K | $181.00K | $190.00K | - | - |
| Rest of world | - | $26.00K | $14.00K | $26.00K | $9.00K | $13.00K | $47.00K | $16.00K | $7.00K | $1.00K | $47.00K | - | - |
| United States | - | $1.62M | $1.66M | $1.73M | $1.93M | $1.81M | $2.67M | $2.41M | $2.31M | $1.84M | $2.40M | - | - |
| U | - | - | - | - | - | - | - | - | - | - | - | $2.75M | $2.63M |
| Non Us | - | - | - | - | - | - | - | - | - | - | - | $32.00K | $29.00K |
ReShape Lifesciences's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (84.63%), Europe (10.08%), AUSTRALIA (5.24%), and Non-US (0.05%).
ReShape Lifesciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HSCS | Heart Test Laboratories | $18.60M | $14.70K |
| NUWE | Nuwellis | $8.86M | $2.19M |
| RSLS | ReShape Lifesciences | $8.68M | $1.97M |
| NURO | NeuroMetrix | $5.90M | $769.15K |
| OPGN | OpGen | $3.42M | $28.00K |
| INVO | INVO Bioscience | $3.02M | $1.58M |
| TNON | Tenon Medical | $2.93M | $719.00K |
| SINT | Sintx | $2.63M | $687.00K |
| TIVC | Tivic Health Systems | $1.18M | $140.00K |
| HSDT | Helius Medical | $644.00K | $182.00K |
| TLIS | Talis Biomedical | $412.00K | - |
| IINN | Inspira Technologies Oxy B.H.N. | - | - |
| BBLG | Bone Biologics | - | - |
RSLS Revenue FAQ
What is ReShape Lifesciences’s yearly revenue?
ReShape Lifesciences's yearly revenue for 2023 was $8.68M, representing a decrease of -22.79% compared to 2022. The company's yearly revenue for 2022 was $11.24M, representing a decrease of -17.35% compared to 2021. RSLS's yearly revenue for 2021 was $13.6M, representing an increase of 20.36% compared to 2020.
What is ReShape Lifesciences’s quarterly revenue?
ReShape Lifesciences's quarterly revenue for Q2 2024 was $1.96M, a 1.08% increase from the previous quarter (Q1 2024), and a -12.82% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.94M, a -1.92% decrease from the previous quarter (Q4 2023), and a -15.00% decrease year-over-year (Q1 2023). RSLS's quarterly revenue for Q4 2023 was $1.98M, a -8.03% decrease from the previous quarter (Q3 2023), and a -36.27% decrease year-over-year (Q4 2022).
What is ReShape Lifesciences’s revenue growth rate?
ReShape Lifesciences's revenue growth rate for the last 3 years (2021-2023) was -36.19%, and for the last 5 years (2019-2023) was -42.49%.
What are ReShape Lifesciences’s revenue streams?
ReShape Lifesciences's revenue streams in c 18 are Product
What is ReShape Lifesciences’s main source of revenue?
For the fiscal year ending Dec 18, the largest source of revenue of ReShape Lifesciences was Product. This segment made a revenue of $606.71K, representing 100.00% of the company's total revenue.